B + L’s Victus femtosecond laser cleared by FDA

Have you gotten a chance to read the August 8th issue of the Ophthalmology Times eReport? In this e-newsletter we released information on the Victus femtosecond laser receiving FDA approval, separate and combined cataract surgery, a protein that may block diabetic retinopathy damage (atypical protein kinase C), and more. Check out the articles in this issue below.

And please follow us on Twitter and Facebook

Femtosecond laser cleared by FDA

Bausch + Lomb (B + L) and Technolas Perfect Vision GmbH (TPV) have received 510(k) clearance from the FDA for a femtosecond laser platform (Victus), and it is now available for shipment within the United States. Read more

Combined or separate cataract, DSAEK procedures in Fuchs’ dystrophy?

In patients who present with both cataract and Fuchs’ endothelial corneal dystrophy, ophthalmologists have the option of performing cataract extraction alone or simultaneously with Descemet’s stripping automated endothelial keratoplasty (DSAEK), said Anthony Aldave, MD, at the 29th annual Current Concepts in Ophthalmology conference. Careful patient selection and informed consent are vital to choosing the proper approach. Read more

Cataract surgery reduces hip fracture risk

Patients who had cataract removal surgery were found to have a 16% decrease in the risk of hip fracture compared with patients who did not undergo the procedure, according to an observational study of more than 400,000 Medicare beneficiaries. Read more

Protein may block diabetic retinopathy damage

A protein that could “interrupt” the chain of events that causes retinal damage in diabetic retinopathy has been identified by researchers at the University of Michigan Kellogg Eye Center. The finding could lead to a therapy that targets two mechanisms at the root of the disease: inflammation and the weakening of the blood barrier that protects the retina. Read more

Jason Woody honored by EBAA

Jason Woody, president and chief executive officer of the Lions Eye Institute for Transplant & Research (LEITR), has received the Leonard Heise Award from the Eye Bank Association of America (EBAA). Read more

Prevent Blindness America Swing Fore Sight Golf Tournament supports eye programs

Sight-saving programs of Prevent Blindness America (PBA) will be supported by the 5th Annual Swing Fore Sight Golf Tournament, a four-person scramble set for Sept. 5 at the Royal Links Golf Club in Las Vegas. Read more

Bryan Lee, MD, JD, wins Vanguard Ophthalmology Society Scholar Award

Bryan S. Lee, MD, JD, a cornea, glaucoma, and refractive surgery fellow at Minnesota Eye Consultants, is the inaugural recipient of the Vanguard Ophthalmology Society Scholar Award. Read more

Haag-Streit, Reliance Medical Products name Ernest Cavin president, CEO

Ernest Cavin, MBA, DBA, has been named president and chief executive officer (CEO) of Haag-Streit USA and Reliance Medical Products, both based in Mason, OH. Read more

Sightpath expands social media efforts

Sightpath, a provider of mobile and fixed ophthalmic surgical products, has created a company blog, a Facebook page, a Twitter account, and a Vimeo channel, as well as a fortified LinkedIn profile. Read more

Check out Ophthalmology Times on Twitter and FacebookLaser, FDA, femtosecond

Advertisements

Optic neuritis treatments vary greatly for NMO and MS

Did you miss the July 18th issue of the Ophthalmology Times eReport? In this e-newsletter we released information on optic neuritis treatments, the Women in Ophthalmology (WIO) summer symposium, transcorneal electrical stimulation, and more. Check out the articles in this issue below.

Optic neuritis treatments vary greatly for NMO and MS

Optic neuritis in juvenile neuromyelitis optica (NMO) is a potentially blinding disease in pubescent and post-pubescent patients in the French West Indies. The treatments used for relapses of the disease and prevention are not well defined; however, they are very different from those used to treat patients with multiple sclerosis (MS). The critical need is to be able to differentiate between MS and NMO before treatment is initiated to preserve the visual and motor functions of those young patients, according to Rabih Hage, MD. Read more

Oral uveitis agent set for phase III trial

Patient enrollment has been completed for a phase III clinical trial of oral voclosporin (Luveniq, Lux Biosciences) for the treatment of non-infectious uveitis. Read more

Ophthalmic Women Leaders partners with Women in Ophthalmology for WIO Summer Symposium

Ophthalmic Women Leaders (OWL) is participating in the Women in Ophthalmology (WIO) summer symposium in Williamsburg, VA. Read more

RP studies look at implants and transcorneal electrical stimulation

Updates on research into therapies for both early- and late-stage retinitis pigmentosa (RP) were presented at the Retinal International World Congress. Read more

Dr. Osher receives latest Kelman Award at the Brazilian Congress of Ophthalmology

Ophthalmology Times Associate Medical Editor Robert H. Osher, MD, received the Kelman Award at the Brazilian Congress of Ophthalmology. Read more

University of Tennessee to feature lecture by glaucoma expert, M. Bruce Shields, MD

Glaucoma expert M. Bruce Shields, MD, will lecture at the Hamilton Eye Institute at the University of Tennessee (UT) Health Science Center Department of Ophthalmology. Read more

Topcon introduces new device, celebrates 80 years

Topcon Medical Systems has introduced a new computerized lensmeter (CL-300 Computerized Lensmeter) in U.S and Latin American markets. Read more

Optic-neuritis treatment modern medicine